Remote monitoring of antiseizure medications at home through microsampling devices in epilepsy

Wednesday June 10th, 2026 - 11am ET, 4pm BST, 5pm CET

Register Now

Exploring the clinical implementation of at-home microsampling for the remote therapeutic drug monitoring of patients with epilepsy.

This webinar focuses on the shift toward decentralized care for epilepsy through at-home therapeutic drug monitoring (TDM), covering the integration of microsampling devices – specifically VAMS and quantitative dried blood spots – into the daily lives of patients. By leveraging analytical validation through UHPLC-MS/MS and real-world data, the session highlights how these technologies allow for reliable, fingerprick-based blood collection outside the hospital.

The discussion will cover clinical feasibility, patient autonomy, and the future of personalized, remote management of antiseizure medications.

What you will learn

  • Explore the transition from traditional hospital-based venous sampling to innovative at-home microsampling techniques.
  • Practical insights into the use of VAMS and quantitative dried blood spot devices specifically for epilepsy management, demonstrating the analytical reliability of remote sampling for monitoring multiple antiseizure medications simultaneously.
  • Key findings on patient feasibility and acceptance of at-home collection, illustrating how remote TDM can significantly improve personalized treatment and clinical outcomes.

Speakers

Chiara Cancellerini

PhD fellow, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy

Chiara Cancellerini, PharmD, is a PhD Fellow in Biomedical and Neuromotor Sciences at the University of Bologna and the IRCCS Institute of Neurological Sciences. Her research focuses on clinical pharmacology and epilepsy, with a specialized track record in TDM and pharmacovigilance. She has experience in the analytical and clinical validation of microsampling devices, including VAMS and dried blood spots. During her studies, she spent a research period at Sahlgrenska University Hospital in Gothenburg, Sweden, for her Master’s thesis and conducted further research in Lausanne, Switzerland, to deepen her expertise in population pharmacokinetics.

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with